| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/BRAIN/116.3.497 |
| P698 | PubMed publication ID | 8513389 |
| P50 | author | Yves Agid | Q3573439 |
| Jérôme Blin | Q67209179 | ||
| P2093 | author name string | Vidailhet M | |
| Crouzel C | |||
| Baron JC | |||
| Dubois B | |||
| Pillon B | |||
| Fournier D | |||
| Fiorelli M | |||
| Attar-Lévy D | |||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| positron emission tomography | Q208376 | ||
| P304 | page(s) | 497-510 | |
| P577 | publication date | 1993-06-01 | |
| P1433 | published in | Brain | Q897386 |
| P1476 | title | Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone | |
| P478 | volume | 116 ( Pt 3) |
| Q92017867 | 24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer's Disease: Analyses from a Clinical Trial with Nabilone |
| Q34192729 | 5-HT radioligands for human brain imaging with PET and SPECT |
| Q44359157 | 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study |
| Q34460504 | A biogenic amine-synapse mechanism for mental retardation and developmental disabilities |
| Q36739665 | A review of the literature on neuroimaging of serotoninergic function in Alzheimer's disease and related disorders |
| Q30619534 | A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophrenia |
| Q31033082 | Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia |
| Q34134270 | Age-related decline of serotonin transporters in living human brain of healthy males |
| Q73154145 | Age-related reduction of [11C]MDL100,907 binding to central 5-HT(2A) receptors: PET study in the conscious monkey brain |
| Q34646469 | Ammonia and Alzheimer's disease |
| Q33790830 | Amyloid beta peptide membrane perturbation is the basis for its biological effects |
| Q30651933 | Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans. |
| Q35236407 | Brain aging research at the close of the 20th century: from bench to bedside |
| Q60512507 | Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease (Review) |
| Q38166965 | Current status of positron emission tomography radiotracers for serotonin receptors in humans |
| Q98564486 | Dementia-Related Psychosis and the Potential Role for Pimavanserin |
| Q28476572 | Dopaminergic and serotonergic drug use: a nationwide register-based study of over 1,300,000 older people |
| Q26749755 | Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT |
| Q36779439 | Drugs of abuse and the aging brain |
| Q51812388 | Effects of aging on 5-HT(2A) R binding: a HRRT PET study with and without partial volume corrections. |
| Q30577801 | Emission tomography contribution to clinical neurology |
| Q35375565 | Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone |
| Q43548437 | Gender-specific aging effects on the serotonin 1A receptor. |
| Q30807356 | Imaging methods for evaluating brain function in man. |
| Q34192772 | Imaging of the 5-HT2A system: age-, gender-, and Alzheimer's disease-related findings |
| Q91899824 | Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience |
| Q48143733 | Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons |
| Q43144400 | Is desire for social relationships mediated by the serotonergic system in the prefrontal cortex? An [(18)F]setoperone PET study |
| Q41043427 | Localization of 5-HT2A receptor in rat cerebral cortex and olfactory system revealed by immunohistochemistry using two antibodies raised in rabbit and chicken |
| Q51974359 | Long-term estrogen therapy and 5-HT(2A) receptor binding in postmenopausal women; a single photon emission tomography (SPET) study. |
| Q45155062 | Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease |
| Q36724965 | Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease |
| Q50583224 | Molecular imaging of serotonin degeneration in mild cognitive impairment. |
| Q30585270 | Neuropharmacology and receptor studies in the elderly |
| Q36020776 | Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease |
| Q35692947 | Positron emission tomography imaging of the aging brain |
| Q48767945 | Preclinical evaluation of [123I]R93274 as a SPECT radiotracer for imaging 5-HT2A receptors |
| Q43597632 | Prolactin response to d-fenfluramine in postmenopausal women on and off ERT: comparison with young women. |
| Q48958711 | Radioligands for brain 5-HT2 receptor imaging in vivo: why do we need them? |
| Q33520683 | Radiopharmaceuticals for positron emission tomography investigations of Alzheimer's disease |
| Q48387869 | Radiosynthesis of [11C]Lu 29-024: a potential radiotracer for 5HT2 receptors PET studies |
| Q28289499 | Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction |
| Q48260915 | Relationship between central and peripheral serotonin 5-HT2A receptors: a positron emission tomography study in healthy individuals |
| Q43577897 | Reproducibility of in vivo brain measures of 5-HT2A receptors with PET and. |
| Q37790804 | Review: disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias |
| Q34185330 | Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies |
| Q73196400 | Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging |
| Q33478744 | Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT2A) receptors in older, healthy adults |
| Q31105327 | The application of positron-emitting molecular imaging tracers in Alzheimer's disease |
| Q48288084 | The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine |
| Q37830311 | The role of G protein-coupled receptors in the pathology of Alzheimer's disease |
| Q34897526 | The role of molecular imaging in the diagnosis and management of neuropsychiatric disorders |
| Q40382126 | Traditional receptor theory and its application to neuroreceptor measurements in functional imaging |
| Q34046040 | Unveiling molecular events in the brain by noninvasive imaging |
| Q42551482 | Validation and quantification of [18F]altanserin binding in the rat brain using blood input and reference tissue modeling |
| Q28303346 | Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging |
Search more.